Latest Asx News

Fiducian Group Limited has voluntarily released its Appendix 4C for Q3 2025, reporting steady net inflows to its core platform and a rise in total funds under management to $15.6 billion.

Perpetual Resources has launched a systematic exploration program across its key lithium projects in Brazil, aiming to expand on recent high-grade discoveries and define new drill targets.

Adveritas Limited has reported a record annualised recurring revenue of $12.2 million for the September 2025 quarter, driven by strong affiliate momentum and initial commercialisation of its Meta integration. The company is advancing its US expansion with a robust trial pipeline and expects significant contract conversions in the coming quarter.

Middle Island Resources has appointed Daniel Raihani as Non-Executive Chairman to steer the company through its pivotal acquisition of Serbian copper-gold assets.

Corazon Mining has completed its acquisition of the Two Pools Gold Project, alongside a $2 million capital raise and a significant share consolidation, positioning itself for accelerated exploration in Western Australia’s prolific Gascoyne region.

RemSense Technologies has landed a pilot project with the Australian Gas Infrastructure Group to deploy its cutting-edge virtualplant platform, marking a key step into Australia’s gas transmission sector.

Lake Resources N.L. has released a replacement prospectus for its bonus loyalty options offer, adjusting key terms and updating its capital structure ahead of the 17 October record date. The offer aims to reward shareholders while potentially raising capital for its Kachi lithium project.

BlackRock Investment Management (Australia) Limited has updated its estimated cash distributions for the iShares Balanced ESG ETF and the iShares High Growth ESG ETF, providing investors with important timetable details and tax compliance reminders.

AuKing Mining advances its strategic acquisition of Orion Resources and the Cloncurry Gold Project while securing a $5 million loan facility and progressing exploration across multiple continents.

Mayne Pharma’s planned acquisition by Cosette Pharmaceuticals faces a delay as the Foreign Investment Review Board postpones its decision, potentially pushing back key court proceedings.

PainChek Limited has confirmed FDA De Novo classification for its PainChek Adult App, promptly disclosing the material regulatory milestone to the ASX and signalling a significant step towards US market entry.

IMDEX Limited reported a resilient FY25 with steady margins, reduced net debt, and strategic acquisitions positioning it for growth. The company’s FY26 outlook is optimistic, supported by improving global exploration activity and technology adoption.